Company Name: MannKind Corporation
MannKind Corporation is a biopharmaceutical company. The company’s FDA approved AFREZZA is a rapid-acting inhaled insulin designed to improve glycemic control in adult diabetics.
Ticker Symbol: MNKD (NASDAQ)
Company Website: www.mannkindcorp.com
Social Media: